Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
Norman G, Rice S, Spackman D, Stirk L, Danso-Appiah A, Suh D
Record ID 32011000767
English
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/0821901/#/
Year Published:
2011
URL for published report:
https://www.journalslibrary.nihr.ac.uk/hta/hta15Suppl1-04#/abstract
Requestor:
NIHR Health Technology Assessment programme
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Trastuzumab
- Antineoplastic Agents
- Receptor, ErbB-2
- Stomach Neoplasms
- Gastrointestinal Neoplasms
- Adenocarcinoma
- Antibodies, Monoclonal, Humanized
- Esophageal Neoplasms
- Esophagogastric Junction
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2011 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.